| Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018 |
201 |
| Epidemiology and Management of Hepatocellular Carcinoma |
178 |
| Epidemiology of Esophageal Squamous Cell Carcinoma |
165 |
| Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions |
114 |
| Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference |
112 |
| Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease |
107 |
| Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy |
97 |
| Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study |
94 |
| Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease |
93 |
| Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease |
86 |
| Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis |
85 |
| Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases |
79 |
| Early Detection of Pancreatic Cancer: Opportunities and Challenges |
70 |
| Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma |
69 |
| The Epidemiology of Esophageal Adenocarcinoma |
68 |
| Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
64 |
| Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases |
64 |
| Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin |
64 |
| Epidemiology and Natural History of Eosinophilic Esophagitis |
63 |
| American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis |
63 |
| Incidence and Etiology of Drug-Induced Liver Injury in Mainland China |
59 |
| Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial |
55 |
| Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease |
55 |
| Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores |
55 |
| Accurate Classification of Diminutive Colorectal Polyps Using Computer-Aided Analysis |
55 |
| Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis |
54 |
| Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial |
54 |
| Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population |
53 |
| Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features |
53 |
| GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease |
52 |
| Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review |
52 |
| Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer |
52 |
| Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis |
52 |
| Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis |
51 |
| Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease |
50 |
| Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses |
50 |
| Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs |
48 |
| Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance |
47 |
| Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors |
46 |
| Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction |
46 |
| Pathophysiology of Eosinophilic Esophagitis |
45 |
| Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity |
45 |
| Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group |
44 |
| Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis |
44 |
| Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities |
44 |
| Super-Enhancer-Driven Long Non-Coding RNA LINC0 Regulated by TP Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma |
42 |
| Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis |
41 |
| Effects of Nutritional Prehabilitation, With and Without Exercise, on Outcomes of Patients Who Undergo Colorectal Surgery: A Systematic Review and Meta-analysis |
41 |
| Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide |
41 |
| Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection |
40 |
| Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics |
40 |
| Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response |
40 |
| Presentation and Epidemiology of Gastroesophageal Reflux Disease |
40 |
| Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients |
39 |
| Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs |
39 |
| Association Between Expression Level of PD1 by Tumor-Infiltrating CD8(+) T Cells and Features of Hepatocellular Carcinoma |
39 |
| Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy |
38 |
| Germline Genetic Features of Young Individuals With Colorectal Cancer |
37 |
| Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016 |
37 |
| Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review |
37 |
| Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice |
36 |
| HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response |
35 |
| Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer |
35 |
| Epidemiology, Pathophysiology, and Treatment of Diverticulitis |
35 |
| Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease |
34 |
| Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition |
34 |
| Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial |
34 |
| RPC a Monoclonal Antibody Against IL Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis |
34 |
| Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases |
34 |
| Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States |
33 |
| Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells |
33 |
| Mitochondrial Dysfunction, Through Impaired Autophagy, Leads to Endoplasmic Reticulum Stress, Deregulated Lipid Metabolism, and Pancreatitis in Animal Models |
33 |
| Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation |
33 |
| Gastroenterologist-Level Identification of Small-Bowel Diseases and Normal Variants by Capsule Endoscopy Using a Deep-Learning Model |
32 |
| Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers |
32 |
| What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection? |
32 |
| Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review |
32 |
| Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data |
32 |
| Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma |
32 |
| AGA Clinical Practice Update: Coagulation in Cirrhosis |
32 |
| Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes |
32 |
| Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease |
32 |
| Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma |
31 |
| Management of Gastroesophageal Reflux Disease |
31 |
| Approaches, Progress, and Challenges to Hepatitis C Vaccine Development |
31 |
| An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis |
31 |
| Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes |
31 |
| Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer |
31 |
| Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring |
30 |
| Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice |
30 |
| Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis |
30 |
| Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study |
30 |
| Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial |
29 |
| Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut - Brain Interaction): A Rome Foundation Working Team Report |
29 |
| Initial Medical Treatment of Acute Pancreatitis: American Gastroenterological Association Institute Technical Review |
29 |
| Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice |
29 |
| Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia |
29 |
| MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1 |
29 |
| Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries |
29 |
| Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals |
29 |
| Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges |
29 |
| Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial |
29 |
| Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials |
29 |
| Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease |
29 |
| Targeted and Immune-Based Therapies for Hepatocellular Carcinoma |
28 |
| Pathophysiology of Gastroesophageal Reflux Disease |
28 |
| Acute Pancreatitis: A Multifaceted Set of Organelle and Cellular Interactions |
27 |
| DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome |
27 |
| Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis |
27 |
| Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia |
27 |
| Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection |
27 |
| Association Between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas |
26 |
| Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease |
26 |
| Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice |
26 |
| AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis |
26 |
| Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma |
26 |
| Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark |
26 |
| In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration |
26 |
| Current Concepts in Severe Acute and Necrotizing Pancreatitis: An Evidence-Based Approach |
25 |
| Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis |
25 |
| Intestinal Dysbiosis Featuring Abundance of &ITRuminococcus gnavus &ITAssociates With Allergic Diseases in Infants |
25 |
| Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis |
25 |
| Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features |
25 |
| Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension |
25 |
| Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity |
25 |
| Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery |
24 |
| Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection |
24 |
| Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection |
24 |
| Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases |
24 |
| Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease |
24 |
| Comparison of Underwater vs Conventional Endoscopic Mucosal Resection of Intermediate-Size Colorectal Polyps |
24 |
| Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis |
24 |
| Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation |
24 |
| Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants |
24 |
| World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer |
24 |
| NF kappa B in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12 |
24 |
| Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases |
24 |
| Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy |
24 |
| Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease |
24 |
| Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis |
24 |
| Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice |
24 |
| Organ Failure Due to Systemic Injury in Acute Pancreatitis |
24 |
| Early Intra-Acinar Events in Pathogenesis of Pancreatitis |
24 |
| Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells |
23 |
| Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events |
23 |
| No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies |
23 |
| Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection |
23 |
| TRIB3 Interacts With beta-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis |
23 |
| P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts |
23 |
| Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver |
22 |
| Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia |
22 |
| Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer |
22 |
| Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden |
22 |
| Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E |
22 |
| Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial |
22 |
| Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis |
22 |
| TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues |
22 |
| Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas |
22 |
| Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma |
22 |
| Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome |
22 |
| Diagnosis and Treatment of Eosinophilic Esophagitis |
22 |
| Genetics, Cell Biology, and Pathophysiology of Pancreatitis |
22 |
| Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response |
21 |
| A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury |
21 |
| AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review |
21 |
| HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon |
21 |
| The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis |
21 |
| Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breasffeeding on Infections and Development |
21 |
| Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome |
21 |
| Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection |
20 |
| Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins |
20 |
| Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure |
20 |
| Advances in CRC Prevention: Screening and Surveillance |
20 |
| Reserve Stem Cells in Intestinal Homeostasis and Injury |
20 |
| Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals |
20 |
| Superiority of Step-up Approach vs Open Necrosectomy in Long-term Follow-up of Patients With Necrotizing Pancreatitis |
20 |
| Long Noncoding RNA uc.173 Promotes Renewal of the Intestinal Mucosa by Inducing Degradation of MicroRNA 195 |
20 |
| MicroRNA Regulated by GRLH Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease |
20 |
| Advances in Evaluation of Chronic Diarrhea in Infants |
20 |
| Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis |
20 |
| Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death |
20 |
| Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States |
20 |
| Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis |
20 |
| Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders |
20 |
| Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease |
20 |
| Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease |
19 |
| microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients |
19 |
| Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1 |
19 |
| Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency |
19 |
| Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy |
19 |
| Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV |
19 |
| No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis |
19 |
| Narrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials |
19 |
| Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years |
19 |
| Over-the-Scope Clips Are More Effective Than Standard Endoscopic Therapy for Patients With Recurrent Bleeding of Peptic Ulcers |
19 |
| Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis |
19 |
| Gastric Parietal Cell Physiology and Helicobacter pylori-Induced Disease |
18 |
| MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice |
18 |
| Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice |
18 |
| Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure |
18 |
